| 1 |
Satoh T, Uojima H, Wada N, Takiguchi H, Kaneko M, Nakamura M, Gonda N, Homma M, Hidaka H, Kusano C, Horie R. Introduction of direct-acting antiviral agents alters frequencies of anti-GPIIb/IIIa antibody-producing B cells in chronic hepatitis C patients with thrombocytopenia. Platelets 2023;34:2161498. [PMID: 36597279 DOI: 10.1080/09537104.2022.2161498] [Reference Citation Analysis]
|
| 2 |
Lin Y, Wei H. Platelet Abnormalities after Splenectomy for Hypersplenism in Decompensated Cirrhosis: A Case Report. AJST 2023;5:75-77. [DOI: 10.54097/ajst.v5i1.5391] [Reference Citation Analysis]
|
| 3 |
Biolato M, Vitale F, Galasso T, Gasbarrini A, Grieco A. Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines. World J Gastrointest Surg 2023; 15(2): 127-141 [DOI: 10.4240/wjgs.v15.i2.127] [Reference Citation Analysis]
|
| 4 |
Lee C, Shen C, Yen C, Yen T, Hsieh S. Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy. JPM 2023;13:397. [DOI: 10.3390/jpm13030397] [Reference Citation Analysis]
|
| 5 |
Chen Y, Yang C, Huang S, Liu J, Wang Y, Zhou C, Li T, Wang C, Ju S, Bai Y, Yao W, Xiong B. The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Sci Rep 2023;13:1633. [PMID: 36717590 DOI: 10.1038/s41598-023-28646-5] [Reference Citation Analysis]
|
| 6 |
Yoshida H, Ohki T, Kanezaki M, Teratani T, Sato S, Obi S, Sato T, Akamatsu M, Uchino K, Taniguchi H. Safe radiofrequency ablation for low platelet count patients with a novel platelet count raising drug (lusutrombopag): Prospective Observational Study.. [DOI: 10.21203/rs.3.rs-2423711/v1] [Reference Citation Analysis]
|
| 7 |
Vörös K, Márkus B, Atzél K, Szalay F, Gráf L, Németh D, Masszi T, Torzsa P, Kalabay L. Serum fetuin-A is decreased in cirrhotic patients with Wilson's disease. PLoS One 2023;18:e0282801. [PMID: 36881584 DOI: 10.1371/journal.pone.0282801] [Reference Citation Analysis]
|
| 8 |
Huang L, Yu Q, Peng H, Zhen Z. Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e32335. [PMID: 36595801 DOI: 10.1097/MD.0000000000032335] [Reference Citation Analysis]
|
| 9 |
Okubo S, Shindoh J, Kobayashi Y, Hashimoto M. New Prediction Model for Platelet Increase After Non-Trauma Splenectomy. Indian J Surg 2022. [DOI: 10.1007/s12262-022-03644-5] [Reference Citation Analysis]
|
| 10 |
Lim HI, Cuker A. Thrombocytopenia and liver disease: pathophysiology and periprocedural management. Hematology Am Soc Hematol Educ Program 2022;2022:296-302. [PMID: 36485111 DOI: 10.1182/hematology.2022000408] [Reference Citation Analysis]
|
| 11 |
Lopez-Delgado JC, Putzu A, Landoni G. The importance of liver function assessment before cardiac surgery: A narrative review. Front Surg 2022;9:1053019. [PMID: 36561575 DOI: 10.3389/fsurg.2022.1053019] [Reference Citation Analysis]
|
| 12 |
La Mura V, Bitto N, Tripodi A. Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges. Expert Rev Hematol 2022;15:1031-44. [PMID: 36342412 DOI: 10.1080/17474086.2022.2144217] [Reference Citation Analysis]
|
| 13 |
Airapetov MI, Eresko SO, Bychkov ER, Lebedev AA, Shabanov PD. Effect of Ethanol on Platelet Biology. Biochem Moscow Suppl Ser B 2022;16:305-317. [DOI: 10.1134/s1990750822040023] [Reference Citation Analysis]
|
| 14 |
Tsukui T, Koga H, Cazares J, Yamada S, Murakami H, Shibuya S, Nakamura H, Ochi T, Tsuboi K, Lane G, Tanaka N, Miyano G, Okazaki T, Urao M, Yamataka A. Biochemical Evaluation of Laparoscopic Portoenterostomy for Treating Biliary Atresia and Redo for Failed Portoenterostomy. J Laparoendosc Adv Surg Tech A 2022;32:1212-9. [PMID: 35939285 DOI: 10.1089/lap.2022.0245] [Reference Citation Analysis]
|
| 15 |
Schaefer N, Grözinger G, Pech M, Pfammatter T, Soydal C, Arnold D, Kolligs F, Maleux G, Munneke G, Peynircioglu B, Sangro B, Pereira H, Zeka B, de Jong N, Helmberger T; CIRT Principal Investigators. Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT. Clin Colorectal Cancer 2022;21:285-96. [PMID: 36270925 DOI: 10.1016/j.clcc.2022.09.002] [Reference Citation Analysis]
|
| 16 |
Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271 [DOI: 10.4240/wjgs.v14.i11.1260] [Reference Citation Analysis]
|
| 17 |
Biolato M, Vitale F, Marrone G, Miele L, Grieco A. A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series. Medicine (Baltimore) 2022;101:e31429. [PMID: 36343065 DOI: 10.1097/MD.0000000000031429] [Reference Citation Analysis]
|
| 18 |
Biolato M, Vitale F, Marrone G, Miele L, Grieco A. Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia. Gastroenterol Rep (Oxf) 2022;10:goac059. [PMID: 36340807 DOI: 10.1093/gastro/goac059] [Reference Citation Analysis]
|
| 19 |
Brigida M, Di Caro S, Petruzziello C, Saviano A, Riccioni ME, Franceschi F, Ojetti V. Vitamin-K Antagonists vs. Direct Oral Anticoagulants on Severity of Upper Gastrointestinal Bleeding: A Retrospective Analysis of Italian and UK Data. J Clin Med 2022;11. [PMID: 36362611 DOI: 10.3390/jcm11216382] [Reference Citation Analysis]
|
| 20 |
Aimagambetov MZ, Orazgalieva MT, Omarov NB, Zhanybekov SD, Orazalina AS. Blood Disorders in Patients with Obstructive Jaundice: A Literature Review. Open Access Maced J Med Sci 2022;10:712-719. [DOI: 10.3889/oamjms.2022.10470] [Reference Citation Analysis]
|
| 21 |
Minina MG, Voronov DV, Nevredimov AA, Tenchurina EA. Predictors of hepatic steatosis in living liver donors. RJTAO 2022;24:118-123. [DOI: 10.15825/1995-1191-2022-4-118-123] [Reference Citation Analysis]
|
| 22 |
Sumitomo NF, Tamura M, Asano S, Yuasa E, Oyanagi T, Inoue M, Kodo K, Yamagishi H. Successful Preoperative Partial Splenic Artery and Aneurysm Embolization for Thrombocytopenia Associated with Failed Fontan Circulation. Int Heart J 2022. [PMID: 36104230 DOI: 10.1536/ihj.22-083] [Reference Citation Analysis]
|
| 23 |
Satoh T, Takiguchi H, Uojima H, Kubo M, Tanaka C, Yokoyama F, Wada N, Miyazaki K, Hidaka H, Kusano C, Kuwana M, Horie R. B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis. Ann Hematol 2022. [PMID: 36098792 DOI: 10.1007/s00277-022-04973-x] [Reference Citation Analysis]
|
| 24 |
Wu HG, Wu H, Cheng C, Chen J, Chen T, Li C, Shen C. Serial platelet level index improves prediction of pulmonary hemorrhage in patients with Stenotrophomonas maltophilia respiratory infections and thrombocytopenia. Front Med 2022;9. [DOI: 10.3389/fmed.2022.940159] [Reference Citation Analysis]
|
| 25 |
Wang C, Yao J, Niu H, Yang C, Liu J, Bai Y, Ju S, Xiong B. Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. Journal of Interventional Medicine 2022. [DOI: 10.1016/j.jimed.2022.09.001] [Reference Citation Analysis]
|
| 26 |
Ishikawa T. Efficacy of interventional radiology in the management of portal hypertension: A narrative review. Medicine (Baltimore) 2022;101:e30018. [PMID: 35984127 DOI: 10.1097/MD.0000000000030018] [Reference Citation Analysis]
|
| 27 |
Brusilovskaya K, Simbrunner B, Lee S, Eichelberger B, Bauer D, Zinober K, Schwabl P, Mandorfer M, Panzer S, Reiberger T, Gremmel T. Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis. Platelets 2022;33:879-86. [PMID: 35294323 DOI: 10.1080/09537104.2021.2007868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Gallo P, Terracciani F, Di Pasquale G, Esposito M, Picardi A, Vespasiani-Gentilucci U. Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures. World J Gastroenterol 2022; 28(30): 4061-4074 [DOI: 10.3748/wjg.v28.i30.4061] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Flamm SL, Peck-Radosavljevic M, Fukuhara T, Bentley R, Katsube T, Ochiai T, Kano T, Tsukimura E, Sasaki R, Osaki Y. Pharmacokinetic Assessment and Treatment Effect of Lusutrombopag in Child-Pugh Class C Patients: Review of Patient Data from Two Clinical Studies and Post-Marketing Surveillance. Adv Ther 2022. [PMID: 35904722 DOI: 10.1007/s12325-022-02237-8] [Reference Citation Analysis]
|
| 30 |
Kim M, Ling K, Nazemi A, Tantone R, Kashanchi K, Lung B, Komatsu DE, Wang ED. Abnormal Preoperative Platelet Count May Predict Postoperative Complications Following Shoulder Arthroplasty. JSES International 2022. [DOI: 10.1016/j.jseint.2022.06.008] [Reference Citation Analysis]
|
| 31 |
Salama II, Raslan HM, Abdel-Latif GA, Salama SI, Sami SM, Shaaban FA, Abdelmohsen AM, Fouad WA. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection. World J Hepatol 2022;14:1053-73. [PMID: 35978668 DOI: 10.4254/wjh.v14.i6.1053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Zhang X, Huang WJ, Zhang ML, Wang W, Niu Y, Wang RT, Liu ZY. Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma. BMC Gastroenterol 2022;22:288. [PMID: 35668355 DOI: 10.1186/s12876-022-02348-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Crowley M, Rayman S, Ross S, Crespo K, Syblis C, Sucandy I, Rosemurgy A. Does Preoperative Thrombocytopenia in Patients Undergoing Robotic Hepatectomy for Liver Tumors Predict Poor Outcomes? A Propensity-Score Match Analysis. Am Surg 2022;:31348221087919. [PMID: 35471134 DOI: 10.1177/00031348221087919] [Reference Citation Analysis]
|
| 34 |
Ibrahim RSEA, Abdelmoety AA, Baddour N, Salem P, Metawea M. Narrow band endoscopic diagnosis of portal hypertensive gastropathy in cirrhotic patients. Alexandria Journal of Medicine 2022;58:38-43. [DOI: 10.1080/20905068.2022.2064164] [Reference Citation Analysis]
|
| 35 |
Mastrorilli G, Fiorentino F, Tucci C, Lombardi G, Aghemo A, Colombo GL. Cost Analysis of Platelet Transfusion in Italy for Patients with Chronic Liver Disease and Associated Thrombocytopenia Undergoing Elective Procedures. CEOR 2022;Volume 14:205-20. [DOI: 10.2147/ceor.s354470] [Reference Citation Analysis]
|
| 36 |
Eguchi Y, Takahashi H, Mappa S, Santagostino E. Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia. Hepatol Res 2022;52:371-80. [PMID: 35134259 DOI: 10.1111/hepr.13755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Airapetov M, Eresko S, Bychkov E, Lebedev A, Shabanov P. Effect of ethanol on platelet biology. BIOMED KHIM 2022;68:81-92. [DOI: 10.18097/pbmc20226802081] [Reference Citation Analysis]
|
| 38 |
Fujimori N, Kimura T, Tanaka N, Yamazaki T, Okumura T, Kobayashi H, Wakabayashi SI, Yamashita Y, Sugiura A, Pham J, Pydi SP, Sano K, Joshita S, Umemura T. 2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease. Hepatol Res 2022;52:352-63. [PMID: 35040549 DOI: 10.1111/hepr.13745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 39 |
Zafar F, Lubert AM, Trout AT, Katz DA, Palermo JJ, Opotowsky AR, Lorts A, Chin C, Powell AW, Villa CR, Anwar N, Morales DL, Dillman JR, Alsaied T. Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation. Radiology 2022;:211037. [PMID: 35289663 DOI: 10.1148/radiol.211037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Chen YC, Liou YT, Tsai WH, Chen LW. Prognostic Role of Subsequent Thrombocytopenia in Necrotizing Fasciitis Without Liver Disease. Ann Plast Surg 2022;88:S99-S105. [PMID: 35225855 DOI: 10.1097/SAP.0000000000003069] [Reference Citation Analysis]
|
| 41 |
Schwabl P, Seeland BA, Riedl F, Schubert TL, Königshofer P, Brusilovskaya K, Petrenko O, Hofer B, Schiefer AI, Trauner M, Peck-Radosavljevic M, Reiberger T. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension. Adv Med Sci 2022;67:154-62. [PMID: 35272246 DOI: 10.1016/j.advms.2022.02.005] [Reference Citation Analysis]
|
| 42 |
Driever EG, Lisman T. Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease. Semin Thromb Hemost 2022. [PMID: 35135033 DOI: 10.1055/s-0042-1742438] [Reference Citation Analysis]
|
| 43 |
Chen Y, Chang T, Chen C, Cheng P, Lo C, Mo L, Chen C, Huang C, Kuo H, Huang Y, Tai C, Peng C, Bair M, Yeh M, Lin C, Lin C, Lee P, Chong L, Hung C, Huang J, Yang C, Hu J, Lin C, Wang C, Su W, Hsieh T, Lin C, Tsai W, Lee T, Chen G, Wang S, Chang C, Yang S, Wu W, Huang C, Hsiung C, Kao C, Tsai P, Liu C, Lee M, Dai C, Kao J, Chuang W, Lin H, Chen C, Tseng K, Yu M; on behalf of TACR investigators. Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals. Viruses 2022;14:333. [DOI: 10.3390/v14020333] [Reference Citation Analysis]
|
| 44 |
Yoshida M, Tateishi R, Hiroi S, Fujiwara M, Kitanishi Y, Iwasaki K, Takeshima T, Igarashi A. Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data. Adv Ther 2022;39:992-1003. [PMID: 34928469 DOI: 10.1007/s12325-021-02008-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Li Q, Guo X, Feng J, Xu X, Chawla S, Li H, Qi X. Risk Factors for Esophageal Collateral Veins in Cirrhosis with and without Previous Endoscopic Esophageal Variceal Therapy. Can J Gastroenterol Hepatol 2022;2022:6666791. [PMID: 35028303 DOI: 10.1155/2022/6666791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 46 |
Yoshida M, Tateishi R, Hiroi S, Hongo Y, Fujiwara M, Kitanishi Y, Iwasaki K, Takeshima T, Igarashi A. Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease. Adv Ther 2022;39:379-90. [PMID: 34748184 DOI: 10.1007/s12325-021-01965-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 47 |
Bucsics T, Lampichler K, Vierziger C, Schoder M, Wolf F, Bauer D, Simbrunner B, Hartl L, Jachs M, Scheiner B, Trauner M, Gruenberger T, Karnel F, Mandorfer M, Reiberger T. Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis. Dig Dis Sci 2022;67:5693-703. [PMID: 35301618 DOI: 10.1007/s10620-022-07443-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 48 |
Sari O, Üre Ü. An evaluation of thrombocytopenia cases in the hematology clinic of the Ankara Numune Training and Research Hospital. Egypt J Haematol 2022;47:35. [DOI: 10.4103/ejh.ejh_56_21] [Reference Citation Analysis]
|
| 49 |
Xu X, Li C, Chen J, Liu X, Su H, Tong J, Hu J. Relationship Between Platelet to White Blood Cell Ratio and 30-Day Prognosis of Patients with Acute-on-Chronic Liver Failure. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.118640] [Reference Citation Analysis]
|
| 50 |
Zhang X, Svn Z, Liv M, Liu M, Zhang Y, Sun Q. Assessment of Prognostic Value of Aspartate Aminotransferase-to-Platelet Ratio Index in Patients With Hepatocellular Carcinoma: Meta-Analysis of 28 Cohort Studies. Front Med (Lausanne) 2021;8:756210. [PMID: 34901068 DOI: 10.3389/fmed.2021.756210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 51 |
Yoshiji H, Ueno Y, Kurosaki M, Torimura T, Hatano E, Yatsuhashi H, Yamakado K. Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures. Hepatol Res 2021;51:1181-95. [PMID: 34555262 DOI: 10.1111/hepr.13715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 52 |
Kuter DJ. The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag. Blood Rev 2021;:100909. [PMID: 34815110 DOI: 10.1016/j.blre.2021.100909] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 53 |
Nguyen G, Lejeune M, Crichi B, Frere C. Hemostasis testing in patients with liver dysfunction: Advantages and caveats. World J Gastroenterol 2021; 27(42): 7285-7298 [PMID: 34876789 DOI: 10.3748/wjg.v27.i42.7285] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 54 |
Chakraborty S, Jana D. ASSOCIATION THROMBOCYTOPENIAAND ITS CO-RELATION IN CHRONIC LIVER DISEASE PATIENTS IN A TERTIARY CARE HOSPITAL. ijsr 2021. [DOI: 10.36106/ijsr/3506443] [Reference Citation Analysis]
|
| 55 |
Gao L, Decker M, Chen H, Ding L. Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation. Elife 2021;10:e69894. [PMID: 34463253 DOI: 10.7554/eLife.69894] [Reference Citation Analysis]
|
| 56 |
Grassi G, Lenci I, Signorello A, Milana M, Baiocchi L. Gastrointestinal endoscopy in cirrhotic patient: Issues on the table. World J Gastrointest Endosc 2021; 13(7): 210-220 [PMID: 34326942 DOI: 10.4253/wjge.v13.i7.210] [Reference Citation Analysis]
|
| 57 |
Oh Y, Yoo SY, Choi GS, Kim G. Liver transplantation of a patient with extreme thrombocytopenia - A case report. Anesth Pain Med (Seoul) 2021;16:279-83. [PMID: 34233411 DOI: 10.17085/apm.21006] [Reference Citation Analysis]
|
| 58 |
Montagnese S, Lauridsen M, Vilstrup H, Zarantonello L, Lakner G, Fitilev S, Zupanets I, Kozlova I, Bunkova E, Tomasiewicz K, Berglund JE, Rorsman F, Hagström H, Kechagias S, Ocklind CE, Mauney J, Thunarf F, Mokhatarani M, Bäckström T, Doverskog M, Lins LE, Månsson M, Samuelson P, Nilsson D, Schalling M, Johansson M, Arlander E, Scharschmidt BF. A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy. J Hepatol 2021;75:98-107. [PMID: 33894327 DOI: 10.1016/j.jhep.2021.03.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 59 |
Ding JN, Zhao WF. Mechanism, diagnosis, and treatment of portal vein thrombosis in cirrhosis. Shijie Huaren Xiaohua Zazhi 2021; 29(12): 670-676 [DOI: 10.11569/wcjd.v29.i12.670] [Reference Citation Analysis]
|
| 60 |
Alvaro D, Caporaso N, Giannini EG, Iacobellis A, Morelli M, Toniutto P, Violi F; PReBRiC (Procedure-Related Bleeding Risk in Cirrhosis) group. Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia. Eur J Clin Invest 2021;51:e13508. [PMID: 33539542 DOI: 10.1111/eci.13508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 61 |
Saif-Al-Islam M, Abdelaal UM, Younis MA, Alghany Algahlan HA, Khalaf S. Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease. Gastroenterol Res Pract 2021;2021:8811203. [PMID: 34122539 DOI: 10.1155/2021/8811203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 62 |
Gao L, Decker M, Chen H, Ding L. Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation.. [DOI: 10.1101/2021.05.13.443980] [Reference Citation Analysis]
|
| 63 |
Scharf RE. Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management. J Clin Med 2021;10:1530. [PMID: 33917431 DOI: 10.3390/jcm10071530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 64 |
Zanetto A, Senzolo M, Campello E, Bulato C, Gavasso S, Shalaby S, Gambato M, Vitale A, Cillo U, Farinati F, Russo FP, Simioni P, Burra P. Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis. Cancers (Basel) 2021;13:1150. [PMID: 33800224 DOI: 10.3390/cancers13051150] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 65 |
Sun X, Zhang A, Zhou T, Wang M, Chen Y, Zhou T, Chen X, Xiu A, Peng Z, Cheng B, Liu X, Gao Y. Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial. Hepatol Int 2021;15:741-52. [PMID: 33638769 DOI: 10.1007/s12072-021-10155-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 66 |
Zanetto A, Rinder HM, Senzolo M, Simioni P, Garcia-Tsao G. Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure-Related Bleeding in Decompensated Cirrhosis. Hepatol Commun 2021;5:272-82. [PMID: 33553974 DOI: 10.1002/hep4.1641] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 67 |
Chen YC, Ko PH, Lee CC, Tseng CW, Tseng KC. Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy. BMC Gastroenterol 2021;21:30. [PMID: 33478399 DOI: 10.1186/s12876-021-01606-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 68 |
Akar M. Is mean platelet volume better than other long-used non-invasive parameters in assessing severe fibrosis in patients with chronic hepatitis B? Journal of Health Sciences and Medicine 2021;4:96-102. [DOI: 10.32322/jhsm.840794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 69 |
Liu J, Ma J, Yang C, Ye T, Meng J, Shi Q, Xiong B. Impact of TIPS on Splenic Volume and Thrombocytopenia. AJR Am J Roentgenol 2021;216:698-703. [PMID: 33439047 DOI: 10.2214/AJR.20.22958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 70 |
Brown RS Jr, Imawari M, Izumi N, Osaki Y, Bentley R, Ochiai T, Kano T, Peck-Radosavljevic M. Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag. JHEP Rep 2021;3:100228. [PMID: 33644726 DOI: 10.1016/j.jhepr.2021.100228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 71 |
Wang J, Zhang P, Liao J, Zhu Y, Liu X, Tang H. Association of α-fetoprotein levels with liver stiffness measurement in outpatients with chronic hepatitis B. Biosci Rep 2021;41:BSR20203048. [PMID: 33289529 DOI: 10.1042/BSR20203048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Dix HM, Robinson EM, Dillon JF. Liver Disorders Related to Alcohol and Other Drug Use. Textbook of Addiction Treatment 2021. [DOI: 10.1007/978-3-030-36391-8_77] [Reference Citation Analysis]
|
| 73 |
de Oliveira Rech B, Rocha Tenório J, Bertoldi Franco J, Medina JB, Gallottini M, Pérez-Sayáns M, Ortega KL. Risk of bleeding during oral surgery in patients with liver cirrhosis: A systematic review. J Am Dent Assoc 2021;152:46-54.e2. [PMID: 33250169 DOI: 10.1016/j.adaj.2020.09.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 74 |
Oliveira APPD, Ferreira AR, Fagundes EDT, Queiroz TCN, Carvalho SD, Neto JAF, Bittencourt PFS. Endoscopic prophylaxis and factors associated with bleeding in children with extrahepatic portal vein obstruction. Jornal de Pediatria (Versão em Português) 2020;96:755-62. [DOI: 10.1016/j.jpedp.2019.08.011] [Reference Citation Analysis]
|
| 75 |
Oliveira APP, Ferreira AR, Fagundes EDT, Queiroz TCN, Carvalho SD, Neto JAF, Bittencourt PFS. Endoscopic prophylaxis and factors associated with bleeding in children with extrahepatic portal vein obstruction. J Pediatr (Rio J) 2020;96:755-62. [PMID: 31666182 DOI: 10.1016/j.jped.2019.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 76 |
Liu PH, Hsu CY, Su CW, Huang YH, Hou MC, Rich NE, Fujiwara N, Hoshida Y, Singal AG, Huo TI. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver Int 2020;40:2522-34. [PMID: 32511831 DOI: 10.1111/liv.14560] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 77 |
Alkhouri N, Imawari M, Izumi N, Osaki Y, Ochiai T, Kano T, Bentley R, Trevisani F. Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 2020;18:2600-2608.e1. [PMID: 32205226 DOI: 10.1016/j.cgh.2020.03.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 78 |
Iimuro Y, Yada A, Okada T, Nakamura I, Suzumura K, Xu J, Sudo M, Nishiguchi S, Kawada N, Hatano E, Fujimoto J. Cytoglobin-expressing cells in the splenic cords contribute to splenic fibrosis in cirrhotic patients. Histol Histopathol 2020;35:1319-28. [PMID: 32945524 DOI: 10.14670/HH-18-257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 79 |
Furuichi Y, Takeuchi H, Yoshimasu Y, Kasai Y, Abe M, Itoi T. Thrombopoietin receptor agonist is more effective than platelet transfusion for chronic liver disease with thrombocytopenia, shown by propensity score matching. Hepatol Res 2020;50:1062-70. [PMID: 32510789 DOI: 10.1111/hepr.13530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 80 |
Chen H, Chen X, Wang G. Platelets: A review of their function and effects in liver diseases. Liver Research 2020;4:129-35. [DOI: 10.1016/j.livres.2020.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 81 |
Silczuk A, Habrat B. Alcohol-induced thrombocytopenia: Current review. Alcohol 2020;86:9-16. [PMID: 32330589 DOI: 10.1016/j.alcohol.2020.02.166] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 82 |
Chen Y, Cai N, Lai Y, Xu W, Li J, Huang L, Huang Y, Hu M, Yang H, Chen J. Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia. Front Pharmacol 2020;11:1137. [PMID: 32792958 DOI: 10.3389/fphar.2020.01137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 83 |
Anugwom C, Ashraf A, Debes JD. Virus-mediated thrombocytopenia in Hepatitis C infection: The impact on fibrosis scores. Dig Liver Dis 2020;52:797-8. [PMID: 32446728 DOI: 10.1016/j.dld.2020.04.027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 84 |
de Souza Silva GA, da Silva SP, da Costa MAS, da Silva AR, de Vasconcelos Alves RR, Ângelo Mendes Tenório FDC, da Silva Melo AR, de Freitas AC, Lagos de Melo CM. SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development. J Gynecol Obstet Hum Reprod 2020;:101846. [PMID: 32599304 DOI: 10.1016/j.jogoh.2020.101846] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 85 |
Zermatten MG, Fraga M, Moradpour D, Bertaggia Calderara D, Aliotta A, Stirnimann G, De Gottardi A, Alberio L. Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis. Hepatology 2020;71:2135-48. [PMID: 32090357 DOI: 10.1002/hep.31201] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 86 |
Adam EH, Möhlmann M, Herrmann E, Schneider S, Zacharowski K, Zeuzem S, Weber CF, Weiler N. Assessment of hemostatic profile in patients with mild to advanced liver cirrhosis. World J Gastroenterol 2020; 26(17): 2097-2110 [PMID: 32536777 DOI: 10.3748/wjg.v26.i17.2097] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 87 |
van Dievoet MA, Eeckhoudt S, Stephenne X. Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade? Int J Mol Sci 2020;21:E3294. [PMID: 32384725 DOI: 10.3390/ijms21093294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 88 |
Zhong LK, Zhang G, Luo SY, Yin W, Song HY. The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B. J Clin Lab Anal 2020;34:e23270. [PMID: 32363594 DOI: 10.1002/jcla.23270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 89 |
Luoto TT, Koivusalo AI, Pakarinen MP. Long-term Outcomes and Health Perceptions in Pediatric-onset Portal Hypertension Complicated by Varices. J Pediatr Gastroenterol Nutr 2020;70:628-34. [PMID: 31990868 DOI: 10.1097/MPG.0000000000002643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 90 |
Park J, Jeong J, Choi HJ, Shim JW, Lee HM, Hong SH, Park CS, Choi JH, Chae MS. Role of thrombocytopenia in risk stratification for acute kidney injury after living donor liver transplantation. Platelets 2021;32:453-62. [PMID: 32299264 DOI: 10.1080/09537104.2020.1754377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 91 |
Newland A, Bentley R, Jakubowska A, Liebman H, Lorens J, Peck-Radosavljevic M, Taieb V, Takami A, Tateishi R, Younossi ZM. A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia. Hematology 2019;24:679-719. [PMID: 31581933 DOI: 10.1080/16078454.2019.1662200] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 92 |
Shirley M, McCafferty EH, Blair HA. Lusutrombopag: A Review in Thrombocytopenia in Patients with Chronic Liver Disease Prior to a Scheduled Procedure. Drugs 2019;79:1689-95. [PMID: 31529283 DOI: 10.1007/s40265-019-01197-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 93 |
Mandorfer M, Peck-Radosavljevic M, Ferenci P, Reiberger T. Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient. Liver Int 2020;40:988-9. [PMID: 31612610 DOI: 10.1111/liv.14273] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 94 |
Li S, Huang N, Dang X, Li L, Li Z, Zhang C, Jiang A, Kong G, Ji F, Yang J, Li Z. A Comparison of Splenic Pathologic Change and Immune Function in HBV-Related Portal Hypertension and Chinese Budd-Chiari Syndrome Patients with Hypersplenism. Viral Immunol 2020;33:112-21. [PMID: 32101101 DOI: 10.1089/vim.2019.0146] [Reference Citation Analysis]
|
| 95 |
Singh N, Bansal P, Maithani M, Chauhan Y. Development and validation of novel LC–MS/MS method for determination of Lusutrombopag in rat plasma and its application to pharmacokinetic studies. Arabian Journal of Chemistry 2020;13:4162-9. [DOI: 10.1016/j.arabjc.2019.06.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 96 |
Sangro B, Chan SL, Meyer T, Reig M, El-Khoueiry A, Galle PR. Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma. J Hepatol 2020;72:320-41. [PMID: 31954495 DOI: 10.1016/j.jhep.2019.10.021] [Cited by in Crossref: 101] [Cited by in F6Publishing: 110] [Article Influence: 33.7] [Reference Citation Analysis]
|
| 97 |
Lin CH, Ho CM, Wu CH, Liang PC, Wu YM, Hu RH, Lee PH, Ho MC. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis. Surg Endosc 2020;34:5566-73. [PMID: 31993821 DOI: 10.1007/s00464-019-07357-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 98 |
Ishizu Y, Ishigami M, Hayashi K, Honda T, Kuzuya T, Ito T, Fujishiro M. Rapid increase of platelet counts during antiviral therapy in patients with hepatitis C virus infection. Hepatol Res 2020;50:47-56. [PMID: 31496023 DOI: 10.1111/hepr.13426] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 99 |
Calleja-panero JL, Andrade RJ, Bañares R, Crespo J, Esteban R, Jarque I, Mingot-castellano ME, Romero-gómez M, Muñoz-peñín R, Bentley R, Shepherd J, Gil Aguirre A. Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts. Rev Esp Enferm Dig 2020;112. [DOI: 10.17235/reed.2020.6895/2020] [Reference Citation Analysis]
|
| 100 |
Elsaid MI, Rustgi VK, Loo N, Aggarwal K, Li-mcleod J, Niu X, Poordad F. The burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease. Journal of Medical Economics 2020;23:378-85. [DOI: 10.1080/13696998.2019.1699563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 101 |
Li Q, Wu Y, Zhu Q, Meng F, Lin S, Liu B, Li B, Tang S, Yang Y, Li Y, Yuan S, Chen Y, Qi X. External validation of Liaoning score for predicting esophageal varices in liver cirrhosis: a Chinese multicenter cross-sectional study. Ann Transl Med 2019;7:755. [PMID: 32042771 DOI: 10.21037/atm.2019.11.78] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 102 |
Huang SC, Li L, Rehman MU, Gao JD, Zhang LH, Tong XL, Waqas M, Li JK. Tibial growth plate vascularization is inhibited by the dithiocarbamate pesticide thiram in chickens: potential relationship to peripheral platelet counts alteration. Environ Sci Pollut Res Int 2019;26:36322-32. [PMID: 31713825 DOI: 10.1007/s11356-019-06664-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 103 |
Männistö V, Färkkilä M, Pussinen P, Jula A, Männistö S, Lundqvist A, Valsta L, Salomaa V, Perola M, Åberg F. Serum lipopolysaccharides predict advanced liver disease in the general population. JHEP Rep 2019;1:345-52. [PMID: 32039385 DOI: 10.1016/j.jhepr.2019.09.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 104 |
Abdela J. Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag. Clin Med Insights Blood Disord 2019;12:1179545X19875105. [PMID: 31673229 DOI: 10.1177/1179545X19875105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 105 |
Peck-Radosavljevic M, Simon K, Iacobellis A, Hassanein T, Kayali Z, Tran A, Makara M, Ben Ari Z, Braun M, Mitrut P, Yang SS, Akdogan M, Pirisi M, Duggal A, Ochiai T, Motomiya T, Kano T, Nagata T, Afdhal N. Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2). Hepatology 2019;70:1336-48. [PMID: 30762895 DOI: 10.1002/hep.30561] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 106 |
Sasaki R, Shiino C, Imawari M, Bentley R, Cai B, Yoshida M, Afdhal N. Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance. Hepatol Res 2019;49:1169-81. [PMID: 31228221 DOI: 10.1111/hepr.13392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 107 |
Honma Y, Shibata M, Hayashi T, Kusanaga M, Ogino N, Minami S, Kumei S, Oe S, Miyagawa K, Senju M, Matsuoka H, Watanabe T, Hiura M, Abe S, Harada M. Effect of direct-acting antivirals on platelet-associated immunoglobulin G and thrombocytopenia in hepatitis C virus-related chronic liver disease. Liver Int 2019;39:1641-51. [PMID: 31009141 DOI: 10.1111/liv.14120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 108 |
Hsu W, Peng C, Su W, Lai H, Lin C, Chuang P, Chen S, Chen H, Wang H, Huang G. Treatment with direct‐acting antiviral agents is associated with increased platelet count in patients with chronic hepatitis C. Adv in Digestive Med 2019;6:109-115. [DOI: 10.1002/aid2.13124] [Reference Citation Analysis]
|
| 109 |
Xu H, Cai R. Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease. Expert Rev Clin Pharmacol 2019;12:859-65. [PMID: 31352834 DOI: 10.1080/17512433.2019.1649137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 110 |
Lu C, White SJ, Ye IB, Mikhail CM, Cheung ZB, Cho SK. The Effects of Liver Disease on Surgical Outcomes Following Adult Spinal Deformity Surgery. World Neurosurg 2019;130:e498-504. [PMID: 31254688 DOI: 10.1016/j.wneu.2019.06.137] [Reference Citation Analysis]
|
| 111 |
Ryan L. Procedural Risk of Bleeding: Does the Management of Thrombocytopenia in Chronic Liver Disease Patients Make a Difference? A Debate. EMJ Hepatol 2019. [DOI: 10.33590/emjhepatol/10313853] [Reference Citation Analysis]
|
| 112 |
Hidaka H, Kurosaki M, Tanaka H, Kudo M, Abiru S, Igura T, Ishikawa T, Seike M, Katsube T, Ochiai T, Kimura K, Fukuhara T, Kano T, Nagata T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M. Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures. Clin Gastroenterol Hepatol 2019;17:1192-200. [PMID: 30502505 DOI: 10.1016/j.cgh.2018.11.047] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 113 |
Scheiner B, Kirstein M, Popp S, Hucke F, Bota S, Rohr-Udilova N, Reiberger T, Müller C, Trauner M, Peck-Radosavljevic M, Vogel A, Sieghart W, Pinter M. Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma. Liver Cancer 2019;8:203-17. [PMID: 31192156 DOI: 10.1159/000489833] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 114 |
McCormick PA, Malone DE, Docherty JR, Kiat C, Christopher BT, Chin JL. Patterns of splenic arterial enhancement on computed tomography are related to changes in portal venous pressure. Eur J Gastroenterol Hepatol 2019;31:352-6. [PMID: 30334908 DOI: 10.1097/MEG.0000000000001286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 115 |
Pluthero FG, Kahr WHA. The Birth and Death of Platelets in Health and Disease. Physiology (Bethesda) 2018;33:225-34. [PMID: 29638183 DOI: 10.1152/physiol.00005.2018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 116 |
Warkentin TE, Mithoowani S, Arnold DM. Acquired Thrombocytopenia. Concise Guide to Hematology 2019. [DOI: 10.1007/978-3-319-97873-4_15] [Reference Citation Analysis]
|
| 117 |
Masuda T, Outani M, Moritomo R, Kobashi H, Shirasuna K, Yoshioka H. A case of lower gingival carcinoma with thrombopenia treated with preoperative administration of Lustrombopag. Journal of Japan Society for Oral Tumors 2019;31:191-195. [DOI: 10.5843/jsot.31.191] [Reference Citation Analysis]
|
| 118 |
Cocero N, Basso M, Grosso S, Carossa S. Direct Oral Anticoagulants and Medical Comorbidities in Patients Needing Dental Extractions: Management of the Risk of Bleeding. J Oral Maxillofac Surg 2019;77:463-70. [PMID: 30347201 DOI: 10.1016/j.joms.2018.09.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 119 |
Shi X, Xia H, Zhang W, Li G, Li A. Radiotherapy for one rectal cancer patient with cirrhosis and moderate to severe thrombocytopenia: a case report. Onco Targets Ther 2018;11:5203-7. [PMID: 30214226 DOI: 10.2147/OTT.S174638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 120 |
Barnett CL, Mladsi D, Vredenburg M, Aggarwal K. Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures. Journal of Medical Economics 2018;21:827-34. [DOI: 10.1080/13696998.2018.1490301] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 121 |
Takahashi K, Nagai S, Safwan M, Liang C, Ohkohchi N. Thrombocytopenia after liver transplantation: Should we care? World J Gastroenterol 2018; 24(13): 1386-1397 [PMID: 29632420 DOI: 10.3748/wjg.v24.i13.1386] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 122 |
Mendes LC, Stucchi RS, Vigani AG. Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies. Hepat Med. 2018;10:13-22. [PMID: 29662329 DOI: 10.2147/hmer.s125234] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 123 |
Droc G. Thrombocytopenia in Liver Transplant. Thrombocytopenia 2018. [DOI: 10.5772/intechopen.72510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 124 |
Gold AK, Patel PA, Lane-Fall M, Gutsche JT, Lauter D, Zhou E, Guelaff E, MacKay EJ, Weiss SJ, Baranov DJ, Valentine EA, Feinman JW, Augoustides JG. Cardiovascular Collapse During Liver Transplantation-Echocardiographic-Guided Hemodynamic Rescue and Perioperative Management. J Cardiothorac Vasc Anesth 2018;32:2409-16. [PMID: 29525193 DOI: 10.1053/j.jvca.2018.01.050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 125 |
Callum J, Janssen HLA, Dzik W. Hematologic Challenges in ICU Patients with Liver Disease and Gastrointestinal Hemorrhage. Hematologic Challenges in the Critically Ill 2018. [DOI: 10.1007/978-3-319-93572-0_9] [Reference Citation Analysis]
|
| 126 |
Pembroke T, Sebastiani G. Non-invasive Serum Markers of Fibrosis. Diagnostic Methods for Cirrhosis and Portal Hypertension 2018. [DOI: 10.1007/978-3-319-72628-1_5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 127 |
Yoshida H, Yamada H, Nogami W, Dohi K, Kurino-Yamada T, Sugiyama K, Takahashi K, Gahara Y, Kitaura M, Hasegawa M, Oshima I, Kuwabara K. Development of a new knock-in mouse model and evaluation of pharmacological activities of lusutrombopag, a novel, nonpeptidyl small-molecule agonist of the human thrombopoietin receptor c-Mpl. Exp Hematol 2018;59:30-39.e2. [PMID: 29274361 DOI: 10.1016/j.exphem.2017.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
